Last 12 months
Inside the activity.
0 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 08, 2024 Filed Oct 9, 2024 13:15 UTC |
Schornstein Alexander10% owner
|
PurchaseCommon Stock | 10,000 | $14.58 | $145,800.00 |
DisclosureSEC source: 0001079973-24-001375 · ownership.xml · nonDerivative · entry 1 Schornstein Alexander · CIK 0001999256 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 703,113 F1 · kind: The sales reported on this Form 4 represent shares purchased by the reporting person on October 8, 2024, from the open market using his personal funds. F2 · price: The price reported is the weighted average at which the shares were purchased. 10,000 shares were purchased on October 8, 2024, in multiple transactions at prices ranging from $14.29 to 14.64. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. Read SEC document |
| October 03, 2024 Filed Oct 4, 2024 20:05 UTC |
Okazaki Jason ADirector · CEO and President
|
SaleCommon Stock | 197 | $14.81 | $2,917.57 |
DisclosureSEC source: 0000950170-24-112896 · ownership.xml · nonDerivative · entry 1 Okazaki Jason A · CIK 0001807214 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,904 F1 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the reporting person. Read SEC document |
| October 03, 2024 Filed Oct 4, 2024 20:05 UTC |
White Nicole SChief Manufacturing Officer
|
SaleCommon Stock | 157 | $14.81 | $2,325.17 |
DisclosureSEC source: 0000950170-24-112897 · ownership.xml · nonDerivative · entry 1 White Nicole S · CIK 0001993254 · Chief Manufacturing Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,911 F1 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the reporting person. Read SEC document |
| August 02, 2024 Filed Aug 5, 2024 20:05 UTC |
Okazaki Jason ADirector · CEO and President
|
SaleCommon Stock | 981 | $14.23 | $13,962.08 |
DisclosureSEC source: 0000950170-24-090724 · ownership.xml · nonDerivative · entry 1 Okazaki Jason A · CIK 0001807214 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,101 F1 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.08 to $14.39, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. Read SEC document |
| August 02, 2024 Filed Aug 5, 2024 20:10 UTC |
White Nicole SChief Manufacturing Officer
|
SaleCommon Stock | 785 | $14.23 | $11,172.51 |
DisclosureSEC source: 0000950170-24-090743 · ownership.xml · nonDerivative · entry 1 White Nicole S · CIK 0001993254 · Chief Manufacturing Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,068 F1 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.08 to $14.39, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. Read SEC document |
| July 05, 2024 Filed Jul 8, 2024 14:48 UTC |
Schornstein Alexander10% owner
|
PurchaseCommon Stock | 4,438 | $12.52 | $55,563.76 |
DisclosureSEC source: 0001079973-24-001035 · ownership.xml · nonDerivative · entry 2 Schornstein Alexander · CIK 0001999256 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 693,113 F1 · kind: The sales reported on this Form 4 represent shares purchased by the reporting person from July 3, 2024, and July 5, 2024, from the open market using his personal funds. F3 · price: The price reported is the midpoint of the price range at which the shares were purchased. 4,438 shares were purchased on July 5, 2024, in multiple transactions ranging from $12.40 to $12.68. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. Read SEC document |
| July 03, 2024 Filed Jul 8, 2024 14:48 UTC |
Schornstein Alexander10% owner
|
PurchaseCommon Stock | 4,562 | $12.29 | $56,066.98 |
DisclosureSEC source: 0001079973-24-001035 · ownership.xml · nonDerivative · entry 1 Schornstein Alexander · CIK 0001999256 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 688,675 F1 · kind: The sales reported on this Form 4 represent shares purchased by the reporting person from July 3, 2024, and July 5, 2024, from the open market using his personal funds. F2 · price: The price reported is the midpoint of the price range at which the shares were purchased. 4,562 shares were purchased on July 3, 2024, in multiple transactions at prices ranging from $11.99 to $12.40. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. Read SEC document |
| June 17, 2024 Filed Jun 21, 2024 00:31 UTC |
GILEAD SCIENCES, INC.10% owner
|
PurchaseWarrant to purchase Common Stock · Derivative | 179,500 | Not disclosed Strike: $17.00 | Not disclosed |
DisclosureSEC source: 0000904454-24-000391 · ownership.xml · derivative · entry 2 GILEAD SCIENCES, INC. · CIK 0000882095 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 179,500 Underlying: Common Stock · 179,500 shares Expires 2029-06-18 F1 · price: Pursuant to a securities purchase agreement between the Issuer and the Reporting Person, the Issuer issued and sold to the Reporting Person in a private placement 179,500 shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), and a warrant to purchase 179,500 shares of Common Stock (the "Warrant") at a combined price of $15.46 per share of Common Stock and accompanying warrant. F2 · derivative.exercise_date: The Warrant is exercisable at any time after the date of issuance and expires on June 18, 2029. A holder of the Warrant may not exercise the Warrant if the holder, together with its affiliates, would beneficially own more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise. F2 · derivative.expiration_date: The Warrant is exercisable at any time after the date of issuance and expires on June 18, 2029. A holder of the Warrant may not exercise the Warrant if the holder, together with its affiliates, would beneficially own more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise. Read SEC document |
| June 17, 2024 Filed Jun 21, 2024 00:31 UTC |
GILEAD SCIENCES, INC.10% owner
|
PurchaseCommon Stock | 179,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000904454-24-000391 · ownership.xml · nonDerivative · entry 1 GILEAD SCIENCES, INC. · CIK 0000882095 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,268,972 F1 · price: Pursuant to a securities purchase agreement between the Issuer and the Reporting Person, the Issuer issued and sold to the Reporting Person in a private placement 179,500 shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), and a warrant to purchase 179,500 shares of Common Stock (the "Warrant") at a combined price of $15.46 per share of Common Stock and accompanying warrant. Read SEC document |
| May 29, 2024 Filed May 30, 2024 20:15 UTC |
Mahony SusanDirector
|
GrantStock Option (right to buy) · Derivative | 2,750 | $0.00 Strike: $15.06 | $0.00 |
DisclosureSEC source: 0000950170-24-066604 · ownership.xml · derivative · entry 1 Mahony Susan · CIK 0001463321 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,750 Underlying: Common Stock · 2,750 shares Expires 2034-05-29 F1 · derivative.exercise_date: Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) May 29, 2025 and (2) the date of the Issuer's 2025 annual meeting of stockholders. Read SEC document |
| May 29, 2024 Filed May 30, 2024 20:15 UTC |
Johnson-Pratt LisaDirector
|
GrantStock Option (right to buy) · Derivative | 2,750 | $0.00 Strike: $15.06 | $0.00 |
DisclosureSEC source: 0000950170-24-066606 · ownership.xml · derivative · entry 1 Johnson-Pratt Lisa · CIK 0001849760 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,750 Underlying: Common Stock · 2,750 shares Expires 2034-05-29 F1 · derivative.exercise_date: Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) May 29, 2025 and (2) the date of the Issuer's 2025 annual meeting of stockholders. Read SEC document |
| May 29, 2024 Filed May 30, 2024 20:15 UTC |
McHutchison John GDirector
|
GrantStock Option (right to buy) · Derivative | 2,750 | $0.00 Strike: $15.06 | $0.00 |
DisclosureSEC source: 0000950170-24-066605 · ownership.xml · derivative · entry 1 McHutchison John G · CIK 0001738125 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,750 Underlying: Common Stock · 2,750 shares Expires 2034-05-29 F1 · derivative.exercise_date: Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) May 29, 2025 and (2) the date of the Issuer's 2025 annual meeting of stockholders. Read SEC document |
| May 29, 2024 Filed May 30, 2024 20:10 UTC |
Consylman GinaDirector
|
GrantStock Option (right to buy) · Derivative | 2,750 | $0.00 Strike: $15.06 | $0.00 |
DisclosureSEC source: 0000950170-24-066584 · ownership.xml · derivative · entry 1 Consylman Gina · CIK 0001546358 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,750 Underlying: Common Stock · 2,750 shares Expires 2034-05-29 F1 · derivative.exercise_date: Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) May 29, 2025 and (2) the date of the Issuer's 2025 annual meeting of stockholders. Read SEC document |
| May 29, 2024 Filed May 30, 2024 20:10 UTC |
Houghton MichaelDirector
|
GrantStock Option (right to buy) · Derivative | 2,750 | $0.00 Strike: $15.06 | $0.00 |
DisclosureSEC source: 0000950170-24-066585 · ownership.xml · derivative · entry 1 Houghton Michael · CIK 0001873008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,750 Underlying: Common Stock · 2,750 shares Expires 2034-05-29 F1 · derivative.exercise_date: Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) May 29, 2025 and (2) the date of the Issuer's 2025 annual meeting of stockholders. Read SEC document |
| May 29, 2024 Filed May 30, 2024 20:05 UTC |
ALTIG ANTHONY EDirector
|
GrantStock Option (right to buy) · Derivative | 2,750 | $0.00 Strike: $15.06 | $0.00 |
DisclosureSEC source: 0000950170-24-066562 · ownership.xml · derivative · entry 1 ALTIG ANTHONY E · CIK 0001215907 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,750 Underlying: Common Stock · 2,750 shares Expires 2034-05-29 F1 · derivative.exercise_date: Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) May 29, 2025 and (2) the date of the Issuer's 2025 annual meeting of stockholders. Read SEC document |
| May 29, 2024 Filed May 30, 2024 20:05 UTC |
RINGO WILLIAM RDirector
|
GrantStock Option (right to buy) · Derivative | 2,750 | $0.00 Strike: $15.06 | $0.00 |
DisclosureSEC source: 0000950170-24-066560 · ownership.xml · derivative · entry 1 RINGO WILLIAM R · CIK 0001238325 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,750 Underlying: Common Stock · 2,750 shares Expires 2034-05-29 F1 · derivative.exercise_date: Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) May 29, 2025 and (2) the date of the Issuer's 2025 annual meeting of stockholders. Read SEC document |
| May 23, 2024 Filed May 24, 2024 20:05 UTC |
Okazaki Jason ADirector · CEO and President
|
SaleCommon Stock | 549 | $14.93 | $8,198.66 |
DisclosureSEC source: 0000950170-24-064552 · ownership.xml · nonDerivative · entry 1 Okazaki Jason A · CIK 0001807214 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,082 F1 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.74 to $15.20, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. F3 · balance_after: Includes 208 shares acquired under the Assembly Biosciences, Inc. Amended and Restated 2018 Employee Stock Purchase Plan on May 14, 2024. Read SEC document |
| May 23, 2024 Filed May 24, 2024 20:10 UTC |
Bjorkquist Jeanette MPrincipal Accounting Officer
|
SaleCommon Stock | 24 | $14.93 | $358.41 |
DisclosureSEC source: 0000950170-24-064589 · ownership.xml · nonDerivative · entry 1 Bjorkquist Jeanette M · CIK 0001945064 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,142 F1 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.74 to $15.20, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. Read SEC document |
| May 23, 2024 Filed May 24, 2024 20:05 UTC |
White Nicole SChief Manufacturing Officer
|
SaleCommon Stock | 172 | $14.93 | $2,568.61 |
DisclosureSEC source: 0000950170-24-064551 · ownership.xml · nonDerivative · entry 1 White Nicole S · CIK 0001993254 · Chief Manufacturing Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,853 F1 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.74 to $15.20, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. Read SEC document |
| May 23, 2024 Filed May 24, 2024 20:10 UTC |
McHutchison John GDirector
|
SaleCommon Stock | 2,117 | $14.93 | $31,614.85 |
DisclosureSEC source: 0000950170-24-064586 · ownership.xml · nonDerivative · entry 1 McHutchison John G · CIK 0001738125 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,104 F1 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.74 to $15.20, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. Read SEC document |
| April 30, 2024 Filed May 1, 2024 20:05 UTC |
Okazaki Jason ADirector · CEO and President
|
SaleCommon Stock | 1,569 | $12.71 | $19,936.97 |
DisclosureSEC source: 0000950170-24-051244 · ownership.xml · nonDerivative · entry 2 Okazaki Jason A · CIK 0001807214 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,423 F2 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.3851 to $12.8847, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. Read SEC document |
| April 30, 2024 Filed May 1, 2024 20:10 UTC |
White Nicole SChief Manufacturing Officer
|
SaleCommon Stock | 1,255 | $12.71 | $15,947.03 |
DisclosureSEC source: 0000950170-24-051271 · ownership.xml · nonDerivative · entry 2 White Nicole S · CIK 0001993254 · Chief Manufacturing Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,025 F2 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.3851 to $12.8847, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. Read SEC document |
| April 29, 2024 Filed May 1, 2024 20:05 UTC |
Delaney William E IVChief Scientific Officer
|
GrantCommon Stock | 3,333 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-051243 · ownership.xml · nonDerivative · entry 1 Delaney William E IV · CIK 0001812734 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,109 F1 · kind: Represents shares of common stock issuable under a performance-based restricted stock unit award dated August 1, 2022. On April 29, 2024, a performance-based vesting condition was achieved. F2 · balance_after: Reflects equitable adjustment of the number of shares beneficially owned by the reporting person resulting from a 1-for-12 reverse stock split of the Issuer's common stock effected February 9, 2023, which is exempt from reporting pursuant to Rule 16a-9. Read SEC document |
| April 29, 2024 Filed May 1, 2024 20:05 UTC |
Okazaki Jason ADirector · CEO and President
|
GrantCommon Stock | 4,166 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-051244 · ownership.xml · nonDerivative · entry 1 Okazaki Jason A · CIK 0001807214 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,992 F1 · shares: Represents shares of common stock issuable under a performance-based restricted stock unit award dated August 1, 2022. On April 29, 2024, a performance-based vesting condition was achieved. Read SEC document |
| April 29, 2024 Filed May 1, 2024 20:10 UTC |
White Nicole SChief Manufacturing Officer
|
GrantCommon Stock | 3,333 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-051271 · ownership.xml · nonDerivative · entry 1 White Nicole S · CIK 0001993254 · Chief Manufacturing Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,280 F1 · shares: Represents shares of common stock issuable under a performance-based restricted stock unit award dated August 1, 2022. On April 29, 2024, a performance-based vesting condition was achieved. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 20:05 UTC |
Okazaki Jason ADirector · CEO and President
|
SaleCommon Stock | 354 | $13.07 | $4,627.45 |
DisclosureSEC source: 0000950170-24-040132 · ownership.xml · nonDerivative · entry 1 Okazaki Jason A · CIK 0001807214 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,826 F1 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.90 to $13.30, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 20:20 UTC |
Bjorkquist Jeanette MPrincipal Accounting Officer
|
SaleCommon Stock | 114 | $13.07 | $1,490.20 |
DisclosureSEC source: 0000950170-24-040180 · ownership.xml · nonDerivative · entry 2 Bjorkquist Jeanette M · CIK 0001945064 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,166 F3 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the reporting person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.90 to $13.30, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 20:25 UTC |
McHutchison John GDirector
|
SaleCommon Stock | 1,206 | $13.07 | $15,764.71 |
DisclosureSEC source: 0000950170-24-040205 · ownership.xml · nonDerivative · entry 1 McHutchison John G · CIK 0001738125 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,221 F1 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.90 to $13.30, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. F3 · balance_after: Reflects equitable adjustment of the number of shares beneficially owned by the reporting person resulting from a 1-for-12 reverse stock split of the Issuer's common stock effected February 9, 2023, which is exempt from reporting pursuant to Rule 16a-9. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 20:15 UTC |
White Nicole SChief Manufacturing Officer
|
SaleCommon Stock | 197 | $13.07 | $2,575.16 |
DisclosureSEC source: 0000950170-24-040162 · ownership.xml · nonDerivative · entry 1 White Nicole S · CIK 0001993254 · Chief Manufacturing Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,947 F1 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.90 to $13.30, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. F3 · balance_after: Reflects equitable adjustment of the number of shares beneficially owned by the reporting person resulting from a 1-for-12 reverse stock split of the Issuer's common stock effected February 9, 2023, which is exempt from reporting pursuant to Rule 16a-9. Read SEC document |
| March 29, 2024 Filed Apr 2, 2024 20:10 UTC |
Delaney William E IVChief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $13.30 | $0.00 |
DisclosureSEC source: 0000950170-24-040149 · ownership.xml · derivative · entry 1 Delaney William E IV · CIK 0001812734 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2034-03-29 F1 · derivative.exercise_date: Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on the first anniversary of the date of grant, March 29, 2025; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2028. Read SEC document |
| March 29, 2024 Filed Apr 2, 2024 20:05 UTC |
Okazaki Jason ADirector · CEO and President
|
GrantStock Option (right to buy) · Derivative | 65,000 | $0.00 Strike: $13.30 | $0.00 |
DisclosureSEC source: 0000950170-24-040132 · ownership.xml · derivative · entry 2 Okazaki Jason A · CIK 0001807214 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2034-03-29 F3 · derivative.exercise_date: Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on the first anniversary of the date of grant, March 29, 2025; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2028. Read SEC document |
| March 29, 2024 Filed Apr 2, 2024 20:20 UTC |
Bjorkquist Jeanette MPrincipal Accounting Officer
|
GrantStock Option (right to buy) · Derivative | 1,550 | $0.00 Strike: $13.30 | $0.00 |
DisclosureSEC source: 0000950170-24-040180 · ownership.xml · derivative · entry 3 Bjorkquist Jeanette M · CIK 0001945064 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,550 Underlying: Common Stock · 1,550 shares Expires 2034-03-29 F5 · derivative.exercise_date: Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on the first anniversary of the date of grant, March 29, 2025; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2028. Read SEC document |
| March 29, 2024 Filed Apr 2, 2024 20:20 UTC |
Bjorkquist Jeanette MPrincipal Accounting Officer
|
GrantCommon Stock | 850 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-040180 · ownership.xml · nonDerivative · entry 1 Bjorkquist Jeanette M · CIK 0001945064 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,280 F1 · shares: Grant of restricted stock units. The restricted stock units vest in four approximately equal installments, assuming continuous service on each vesting date, as follows: March 29, 2025; March 29, 2026; March 29, 2027; and March 29, 2028. F2 · balance_after: Reflects equitable adjustment of the number of shares beneficially owned by the reporting person resulting from a 1-for-12 reverse stock split of the Issuer's common stock effected February 9, 2023, which is exempt from reporting pursuant to Rule 16a-9. Read SEC document |
| March 29, 2024 Filed Apr 2, 2024 20:15 UTC |
White Nicole SChief Manufacturing Officer
|
GrantStock Option (right to buy) · Derivative | 17,500 | $0.00 Strike: $13.30 | $0.00 |
DisclosureSEC source: 0000950170-24-040162 · ownership.xml · derivative · entry 2 White Nicole S · CIK 0001993254 · Chief Manufacturing Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Stock · 17,500 shares Expires 2034-03-29 F4 · derivative.exercise_date: Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on the first anniversary of the date of grant, March 29, 2025; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2028. Read SEC document |
| March 27, 2024 Filed Mar 29, 2024 20:05 UTC |
Okazaki Jason ADirector · CEO and President
|
SaleCommon Stock | 392 | $12.87 | $5,045.04 |
DisclosureSEC source: 0000950170-24-038630 · ownership.xml · nonDerivative · entry 1 Okazaki Jason A · CIK 0001807214 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,180 F1 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the reporting person. F2 · balance_after: Reflects equitable adjustment of the number of shares of common stock beneficially owned by the reporting person as a result of a 1-for-12 reverse stock split of the Issuer's common stock effected February 9, 2024, which is exempt from reporting pursuant to Rule 16a-9. Read SEC document |
| January 18, 2024 Filed Jan 19, 2024 16:01 UTC |
Schornstein Alexander10% owner
|
PurchaseCommon Stock | 345,086 | $0.80 | $276,068.80 |
DisclosureSEC source: 0001079973-24-000085 · ownership.xml · nonDerivative · entry 2 Schornstein Alexander · CIK 0001999256 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,209,372 F1 · kind: The sales reported on this Form 4 represent shares purchased by the reporting person from January 17, 2024, to January 18, 2024, from the open market using his personal funds. F3 · price: 345,086 shares were purchased on January 18, 2024, in multiple transactions at $0.80. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. Read SEC document |
| January 17, 2024 Filed Jan 19, 2024 16:01 UTC |
Schornstein Alexander10% owner
|
PurchaseCommon Stock | 299,994 | $0.78 | $235,195.30 |
DisclosureSEC source: 0001079973-24-000085 · ownership.xml · nonDerivative · entry 1 Schornstein Alexander · CIK 0001999256 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,864,286 F1 · kind: The sales reported on this Form 4 represent shares purchased by the reporting person from January 17, 2024, to January 18, 2024, from the open market using his personal funds. F2 · price: The price reported is the midpoint of the price range at which the shares were purchased. 299,994 shares were purchased on January 17, 2024, in multiple transactions at prices ranging from $0.768 to $0.80. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. Read SEC document |
| November 21, 2023 Filed Nov 22, 2023 21:10 UTC |
Schornstein Alexander10% owner
|
PurchaseCommon Stock | 100,000 | $0.67 | $66,700.00 |
DisclosureSEC source: 0001079973-23-001645 · ownership.xml · nonDerivative · entry 2 Schornstein Alexander · CIK 0001999256 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,564,292 F1 · kind: The sales reported on this Form 4 represent shares purchased by the reporting person from November 20, 2023, to November 21, 2023, from the open market using his personal funds. F3 · price: The 100,000 shares purchased on November 21, 2023, were bought in transactions at prices ranging from $0.6666 to $0.67. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. Read SEC document |
| November 20, 2023 Filed Nov 22, 2023 21:10 UTC |
Schornstein Alexander10% owner
|
PurchaseCommon Stock | 300,000 | $0.72 | $215,400.00 |
DisclosureSEC source: 0001079973-23-001645 · ownership.xml · nonDerivative · entry 1 Schornstein Alexander · CIK 0001999256 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,464,292 F1 · kind: The sales reported on this Form 4 represent shares purchased by the reporting person from November 20, 2023, to November 21, 2023, from the open market using his personal funds. F2 · price: The price reported is a weighted average price. These shares were purchased on November 20, 2023, in multiple transactions at prices ranging from $0.695 to $0.72. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. Read SEC document |
| November 17, 2023 Filed Nov 21, 2023 21:05 UTC |
White Nicole SChief Manufacturing Officer
|
SaleCommon Stock | 477 | $0.69 | $328.65 |
DisclosureSEC source: 0001209191-23-056212 · doc4.xml · nonDerivative · entry 1 White Nicole S · CIK 0001993254 · Chief Manufacturing Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,774 F1 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the reporting person. Read SEC document |
| November 08, 2023 Filed Nov 13, 2023 21:10 UTC |
Gaggar AnujChief Medical Officer
|
GrantStock Options (right to buy) · Derivative | 500,000 | $0.00 Strike: $0.85 | $0.00 |
DisclosureSEC source: 0001209191-23-054973 · doc4.xml · derivative · entry 1 Gaggar Anuj · CIK 0001999576 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2033-11-08 F1 · derivative.exercise_date: Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on the first anniversary of the date of grant, November 8, 2024; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on November 8, 2027. Read SEC document |
| October 03, 2023 Filed Oct 4, 2023 20:10 UTC |
Delaney William E IVChief Scientific Officer
|
SaleCommon Stock | 1,891 | $0.80 | $1,503.91 |
DisclosureSEC source: 0001209191-23-051910 · doc4.xml · nonDerivative · entry 2 Delaney William E IV · CIK 0001812734 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,853 F2 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.79 to $0.83, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. Read SEC document |
| October 03, 2023 Filed Oct 4, 2023 20:05 UTC |
Okazaki Jason ADirector · CEO and President
|
SaleCommon Stock | 2,363 | $0.80 | $1,879.29 |
DisclosureSEC source: 0001209191-23-051888 · doc4.xml · nonDerivative · entry 2 Okazaki Jason A · CIK 0001807214 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 174,923 F2 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.79 to $0.83, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. Read SEC document |
| October 03, 2023 Filed Oct 4, 2023 20:15 UTC |
White Nicole SChief Manufacturing Officer
|
SaleCommon Stock | 1,891 | $0.80 | $1,503.91 |
DisclosureSEC source: 0001209191-23-051934 · doc4.xml · nonDerivative · entry 2 White Nicole S · CIK 0001993254 · Chief Manufacturing Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,251 F2 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.79 to $0.83, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:10 UTC |
Delaney William E IVChief Scientific Officer
|
GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-051910 · doc4.xml · nonDerivative · entry 1 Delaney William E IV · CIK 0001812734 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,744 F1 · shares: Represents shares of common stock issuable under a performance-based restricted stock unit award dated August 1, 2022. On October 2, 2023, a performance-based vesting condition was achieved. These shares of common stock vest in two equal installments, assuming continuous service on each vesting date, as follows: October 2, 2023 and October 2, 2024. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:05 UTC |
Okazaki Jason ADirector · CEO and President
|
GrantCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-051888 · doc4.xml · nonDerivative · entry 1 Okazaki Jason A · CIK 0001807214 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 177,286 F1 · shares: Represents shares of common stock issuable under a performance-based restricted stock unit award dated August 1, 2022. On October 2, 2023, a performance-based vesting condition was achieved. These shares of common stock vest in two equal installments, assuming continuous service on each vesting date, as follows: October 2, 2023 and October 2, 2024. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:15 UTC |
White Nicole SChief Manufacturing Officer
|
GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-051934 · doc4.xml · nonDerivative · entry 1 White Nicole S · CIK 0001993254 · Chief Manufacturing Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,142 F1 · shares: Represents shares of common stock issuable under a performance-based restricted stock unit award dated August 1, 2022. On October 2, 2023, a performance-based vesting condition was achieved. These shares of common stock vest in two equal installments, assuming continuous service on each vesting date, as follows: October 2, 2023 and October 2, 2024. Read SEC document |
| August 02, 2023 Filed Aug 3, 2023 20:10 UTC |
Delaney William E IVChief Scientific Officer
|
SaleCommon Stock | 9,461 | $1.09 | $10,292.62 |
DisclosureSEC source: 0001209191-23-044405 · doc4.xml · nonDerivative · entry 1 Delaney William E IV · CIK 0001812734 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,744 F1 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.0801 to $1.10, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. Read SEC document |
| August 02, 2023 Filed Aug 3, 2023 20:05 UTC |
Okazaki Jason ADirector · CEO and President
|
SaleCommon Stock | 11,827 | $1.09 | $12,866.59 |
DisclosureSEC source: 0001209191-23-044397 · doc4.xml · nonDerivative · entry 1 Okazaki Jason A · CIK 0001807214 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,786 F1 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.0801 to $1.10, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. Read SEC document |
| July 24, 2023 Filed Jul 25, 2023 20:30 UTC |
Bjorkquist Jeanette MPrincipal Accounting Officer
|
SaleCommon Stock | 844 | $1.07 | $900.38 |
DisclosureSEC source: 0001209191-23-043309 · doc4.xml · nonDerivative · entry 1 Bjorkquist Jeanette M · CIK 0001945064 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,688 F1 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.05 to $1.10, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.